Q3-osavuosiraportti
Vain PDF
13 päivää sitten
Tarjoustasot
First North Sweden
Määrä
Osto
295 100
Myynti
Määrä
12 437
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 92 000 | - | - | ||
| 8 000 | - | - |
Ylin
0,171VWAP
Alin
0,171VaihtoMäärä
0 100 000
VWAP
Ylin
0,171Alin
0,171VaihtoMäärä
0 100 000
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 100 000 | 100 000 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 100 000 | 100 000 | 0 | 0 |
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4-osavuosiraportti | 12.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 7.11. | |
| 2025 Q2-osavuosiraportti | 15.8. | |
| 2024 Yhtiökokous | 10.6. | |
| 2025 Q1-osavuosiraportti | 15.5. | |
| 2024 Q4-osavuosiraportti | 21.2. |
Datan lähde: Millistream, Quartr
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·8.6.Aino Health AB – Strong Growth and Profitability Improvement (Investment Analysis June 2025) Introduction Aino Health AB (publ) is a Swedish provider of digital health platforms that help companies and public organizations reduce sick leave and improve employee well-being. The company, listed on Nasdaq First North (ticker: AINO), has shown impressive improvements in both growth and profitability over the past year. This analysis highlights why Aino Health appears to be an attractive investment in June 2025 – with strong fundamental development, a positive technical trend, strategic investments in AI-based SaaS, significant market potential and upcoming triggers that can drive the share further. Company Overview and Business Model Aino Health is a leading player in Corporate Health Management with a scalable Software-as-a-Service (SaaS) model for preventive corporate health. Through the company's platform Aino HealthManager, organizations can digitally manage work capacity, sick leave and health promotion efforts in a systematic way. The business model is scalable – connecting a new customer or more users entails marginally increased costs, which paves the way for rising margins as revenue grows. Fundamental analysis: growth, profitability and key figures Aino Health's financial development has been very positive recently. The company is growing its sales while losses are decreasing drastically and cash flow has turned positive. Key figures (SEK thousand): Q1 2025: Sales 7,378, Profit before tax –554, EBITDA: positive, Cash flow (operating): positive Q1 2024: Sales 5,994, Profit before tax –2,943, EBITDA: negative, Cash flow: negative The company's sales growth amounted to +23% in the first quarter of 2025 compared to the same period last year – a sign of accelerating sales. Revenue for Q1 2025 was 7.38 MSEK compared to 5.99 MSEK in Q1 2024. At the same time, profitability has improved significantly: the result before tax showed a deficit of only –0.554 MSEK. This means that the loss decreased by \~81% in one year, and EBITDA was positive for the first time in the company's history. Cash flow from operating activities was positive in Q1. Technical analysis: trend, volume and upside The Aino share has broken its long-term downtrend over the past year and established a positive trend. The price has risen by about 75% in one year, indicating strong buying interest. After the peak level, the share has consolidated and is trading in June 2025 around 0.18–0.23 SEK per share. It is clear that the share is now in an ascending trend channel with successively higher bottoms and tops. Technically, there is support for the price around \~0.14–0.15 SEK. Further support is assessed at 0.10 SEK. On the upside, 0.36 SEK represents an important resistance – an establishment above 0.36 SEK would technically signal a new breakout, with good potential for continued upside. Trend indicators confirm the positive picture. Strategic initiatives and catalysts Aino Health is implementing a number of strategic initiatives that strengthen the company's market position and future growth opportunities: * AI-driven SaaS platform * New partnerships and customer wins * Expansion in the private sector * Positioning towards EU health reforms * Public sector and welfare goals Market potential The market that Aino addresses – digital health platforms for companies and public actors – has enormous growth potential. Drivers include: * High cost of ill health and sick leave * Increased focus on preventive health * Low penetration – big upside * Public investments in welfare technology Upcoming triggers and catalysts * New customer contracts * Transition to profit * Report date and communication * Owner engagement and possible structural deals * Macro trends that may trigger needs Valuation Aino Health's share looks attractively valued given the company's growth and improved prospects. Currently (price approx. SEK 0.18–0.23) the share is only trading at around \~1.8 times the last 12 months' sales, which is low for a SaaS company. For the long-term investor who enters today, there is a possibility that both the multiple valuation will increase and that earnings per share will start to grow rapidly, which will have a double effect on the share price. Conclusion Aino Health AB has transformed into a company with strong tailwinds. The fundamental picture shows accelerating growth, rapidly improving profitability and a scalable SaaS model that is now starting to deliver positive cash flow. Strategically, Aino is positioning itself at the right time by combining AI and health data in a service that addresses both private and public customers' urgent need to reduce sick leave. Several triggers are in the cards – from new customer contracts to the approaching profit turnaround – that could lift the company further in the coming years. Aino Health AB, as of June 2025, is well positioned to provide high returns to the investor who steps on board today.
·23.12.2024Why is it up for auction?
·23.12.2024In the event of unusually large trade/price fluctuation, an auction will be held to calm down the trade.
·12.10.2023How should you think about the obligation to bid? Do you see any alternatives?
9.6.2022 · Muokattu9.6.2022 · MuokattuJag har haft Aino länge och har därmed sett innehavet minska i värde med ca 80%. Men det finns säkert folk som förlorade ännu mer då aktien gick ner med 96,39% sedan introduktionen. Samtidigt sitter ledningen kvar och vad jag kan se kör de på i gamla spår. Därför vill jag ställa en ärlig fråga till alla Aino-ägare: varför behåller ni aktien? Vad är det ni ser som kan rimligtvis komma att ändra riktningen på bolaget? Kassan är tom (igen) men företaget har säkrat ett konvertibellån. Detta lån kommer att stämplas om till aktier för att det är ju ändå högst osannolikt att Aino, som har misslyckats med att visa lönsamhet under sex år i rad, ska börja göra det i år. Nivån som konverteringen kommer att göras på är inte satt i dagsläget men det lär knappast bli 60-70 öre, utan snarare 10-20 öre. Så, varför behåller ni aktien?
10.6.2022 · Muokattu10.6.2022 · MuokattuÄr i samma situation med dig - innehavet har redan minskat i värde med ca 80%. Tror inte att det kommer hända något som kan ändra riktningen men vill behålla aktien för två orsaker: 1. Om det skulle hända något super positivt 2. Påminnelse för mig själv att använda stop loss Min andel är också så pass liten att det gör ingen skillnad om jag behåller eller säljer den.
31.1.2022 · Muokattu31.1.2022 · MuokattuFörstår inte riktigt hur intresset för Aino kan vara så lågt, tycker de prickar många rätt och har ett riktigt intressant case på gång.Poistettu31.1.2022 · MuokattuPoistettu31.1.2022 · Muokattuunder = kunder
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Q3-osavuosiraportti
Vain PDF
13 päivää sitten
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·8.6.Aino Health AB – Strong Growth and Profitability Improvement (Investment Analysis June 2025) Introduction Aino Health AB (publ) is a Swedish provider of digital health platforms that help companies and public organizations reduce sick leave and improve employee well-being. The company, listed on Nasdaq First North (ticker: AINO), has shown impressive improvements in both growth and profitability over the past year. This analysis highlights why Aino Health appears to be an attractive investment in June 2025 – with strong fundamental development, a positive technical trend, strategic investments in AI-based SaaS, significant market potential and upcoming triggers that can drive the share further. Company Overview and Business Model Aino Health is a leading player in Corporate Health Management with a scalable Software-as-a-Service (SaaS) model for preventive corporate health. Through the company's platform Aino HealthManager, organizations can digitally manage work capacity, sick leave and health promotion efforts in a systematic way. The business model is scalable – connecting a new customer or more users entails marginally increased costs, which paves the way for rising margins as revenue grows. Fundamental analysis: growth, profitability and key figures Aino Health's financial development has been very positive recently. The company is growing its sales while losses are decreasing drastically and cash flow has turned positive. Key figures (SEK thousand): Q1 2025: Sales 7,378, Profit before tax –554, EBITDA: positive, Cash flow (operating): positive Q1 2024: Sales 5,994, Profit before tax –2,943, EBITDA: negative, Cash flow: negative The company's sales growth amounted to +23% in the first quarter of 2025 compared to the same period last year – a sign of accelerating sales. Revenue for Q1 2025 was 7.38 MSEK compared to 5.99 MSEK in Q1 2024. At the same time, profitability has improved significantly: the result before tax showed a deficit of only –0.554 MSEK. This means that the loss decreased by \~81% in one year, and EBITDA was positive for the first time in the company's history. Cash flow from operating activities was positive in Q1. Technical analysis: trend, volume and upside The Aino share has broken its long-term downtrend over the past year and established a positive trend. The price has risen by about 75% in one year, indicating strong buying interest. After the peak level, the share has consolidated and is trading in June 2025 around 0.18–0.23 SEK per share. It is clear that the share is now in an ascending trend channel with successively higher bottoms and tops. Technically, there is support for the price around \~0.14–0.15 SEK. Further support is assessed at 0.10 SEK. On the upside, 0.36 SEK represents an important resistance – an establishment above 0.36 SEK would technically signal a new breakout, with good potential for continued upside. Trend indicators confirm the positive picture. Strategic initiatives and catalysts Aino Health is implementing a number of strategic initiatives that strengthen the company's market position and future growth opportunities: * AI-driven SaaS platform * New partnerships and customer wins * Expansion in the private sector * Positioning towards EU health reforms * Public sector and welfare goals Market potential The market that Aino addresses – digital health platforms for companies and public actors – has enormous growth potential. Drivers include: * High cost of ill health and sick leave * Increased focus on preventive health * Low penetration – big upside * Public investments in welfare technology Upcoming triggers and catalysts * New customer contracts * Transition to profit * Report date and communication * Owner engagement and possible structural deals * Macro trends that may trigger needs Valuation Aino Health's share looks attractively valued given the company's growth and improved prospects. Currently (price approx. SEK 0.18–0.23) the share is only trading at around \~1.8 times the last 12 months' sales, which is low for a SaaS company. For the long-term investor who enters today, there is a possibility that both the multiple valuation will increase and that earnings per share will start to grow rapidly, which will have a double effect on the share price. Conclusion Aino Health AB has transformed into a company with strong tailwinds. The fundamental picture shows accelerating growth, rapidly improving profitability and a scalable SaaS model that is now starting to deliver positive cash flow. Strategically, Aino is positioning itself at the right time by combining AI and health data in a service that addresses both private and public customers' urgent need to reduce sick leave. Several triggers are in the cards – from new customer contracts to the approaching profit turnaround – that could lift the company further in the coming years. Aino Health AB, as of June 2025, is well positioned to provide high returns to the investor who steps on board today.
- ·23.12.2024Why is it up for auction?·23.12.2024In the event of unusually large trade/price fluctuation, an auction will be held to calm down the trade.
- ·12.10.2023How should you think about the obligation to bid? Do you see any alternatives?
- 9.6.2022 · Muokattu9.6.2022 · MuokattuJag har haft Aino länge och har därmed sett innehavet minska i värde med ca 80%. Men det finns säkert folk som förlorade ännu mer då aktien gick ner med 96,39% sedan introduktionen. Samtidigt sitter ledningen kvar och vad jag kan se kör de på i gamla spår. Därför vill jag ställa en ärlig fråga till alla Aino-ägare: varför behåller ni aktien? Vad är det ni ser som kan rimligtvis komma att ändra riktningen på bolaget? Kassan är tom (igen) men företaget har säkrat ett konvertibellån. Detta lån kommer att stämplas om till aktier för att det är ju ändå högst osannolikt att Aino, som har misslyckats med att visa lönsamhet under sex år i rad, ska börja göra det i år. Nivån som konverteringen kommer att göras på är inte satt i dagsläget men det lär knappast bli 60-70 öre, utan snarare 10-20 öre. Så, varför behåller ni aktien?10.6.2022 · Muokattu10.6.2022 · MuokattuÄr i samma situation med dig - innehavet har redan minskat i värde med ca 80%. Tror inte att det kommer hända något som kan ändra riktningen men vill behålla aktien för två orsaker: 1. Om det skulle hända något super positivt 2. Påminnelse för mig själv att använda stop loss Min andel är också så pass liten att det gör ingen skillnad om jag behåller eller säljer den.
- 31.1.2022 · Muokattu31.1.2022 · MuokattuFörstår inte riktigt hur intresset för Aino kan vara så lågt, tycker de prickar många rätt och har ett riktigt intressant case på gång.Poistettu31.1.2022 · MuokattuPoistettu31.1.2022 · Muokattuunder = kunder
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
295 100
Myynti
Määrä
12 437
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 92 000 | - | - | ||
| 8 000 | - | - |
Ylin
0,171VWAP
Alin
0,171VaihtoMäärä
0 100 000
VWAP
Ylin
0,171Alin
0,171VaihtoMäärä
0 100 000
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 100 000 | 100 000 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 100 000 | 100 000 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4-osavuosiraportti | 12.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 7.11. | |
| 2025 Q2-osavuosiraportti | 15.8. | |
| 2024 Yhtiökokous | 10.6. | |
| 2025 Q1-osavuosiraportti | 15.5. | |
| 2024 Q4-osavuosiraportti | 21.2. |
Datan lähde: Millistream, Quartr
Q3-osavuosiraportti
Vain PDF
13 päivää sitten
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4-osavuosiraportti | 12.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 7.11. | |
| 2025 Q2-osavuosiraportti | 15.8. | |
| 2024 Yhtiökokous | 10.6. | |
| 2025 Q1-osavuosiraportti | 15.5. | |
| 2024 Q4-osavuosiraportti | 21.2. |
Datan lähde: Millistream, Quartr
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·8.6.Aino Health AB – Strong Growth and Profitability Improvement (Investment Analysis June 2025) Introduction Aino Health AB (publ) is a Swedish provider of digital health platforms that help companies and public organizations reduce sick leave and improve employee well-being. The company, listed on Nasdaq First North (ticker: AINO), has shown impressive improvements in both growth and profitability over the past year. This analysis highlights why Aino Health appears to be an attractive investment in June 2025 – with strong fundamental development, a positive technical trend, strategic investments in AI-based SaaS, significant market potential and upcoming triggers that can drive the share further. Company Overview and Business Model Aino Health is a leading player in Corporate Health Management with a scalable Software-as-a-Service (SaaS) model for preventive corporate health. Through the company's platform Aino HealthManager, organizations can digitally manage work capacity, sick leave and health promotion efforts in a systematic way. The business model is scalable – connecting a new customer or more users entails marginally increased costs, which paves the way for rising margins as revenue grows. Fundamental analysis: growth, profitability and key figures Aino Health's financial development has been very positive recently. The company is growing its sales while losses are decreasing drastically and cash flow has turned positive. Key figures (SEK thousand): Q1 2025: Sales 7,378, Profit before tax –554, EBITDA: positive, Cash flow (operating): positive Q1 2024: Sales 5,994, Profit before tax –2,943, EBITDA: negative, Cash flow: negative The company's sales growth amounted to +23% in the first quarter of 2025 compared to the same period last year – a sign of accelerating sales. Revenue for Q1 2025 was 7.38 MSEK compared to 5.99 MSEK in Q1 2024. At the same time, profitability has improved significantly: the result before tax showed a deficit of only –0.554 MSEK. This means that the loss decreased by \~81% in one year, and EBITDA was positive for the first time in the company's history. Cash flow from operating activities was positive in Q1. Technical analysis: trend, volume and upside The Aino share has broken its long-term downtrend over the past year and established a positive trend. The price has risen by about 75% in one year, indicating strong buying interest. After the peak level, the share has consolidated and is trading in June 2025 around 0.18–0.23 SEK per share. It is clear that the share is now in an ascending trend channel with successively higher bottoms and tops. Technically, there is support for the price around \~0.14–0.15 SEK. Further support is assessed at 0.10 SEK. On the upside, 0.36 SEK represents an important resistance – an establishment above 0.36 SEK would technically signal a new breakout, with good potential for continued upside. Trend indicators confirm the positive picture. Strategic initiatives and catalysts Aino Health is implementing a number of strategic initiatives that strengthen the company's market position and future growth opportunities: * AI-driven SaaS platform * New partnerships and customer wins * Expansion in the private sector * Positioning towards EU health reforms * Public sector and welfare goals Market potential The market that Aino addresses – digital health platforms for companies and public actors – has enormous growth potential. Drivers include: * High cost of ill health and sick leave * Increased focus on preventive health * Low penetration – big upside * Public investments in welfare technology Upcoming triggers and catalysts * New customer contracts * Transition to profit * Report date and communication * Owner engagement and possible structural deals * Macro trends that may trigger needs Valuation Aino Health's share looks attractively valued given the company's growth and improved prospects. Currently (price approx. SEK 0.18–0.23) the share is only trading at around \~1.8 times the last 12 months' sales, which is low for a SaaS company. For the long-term investor who enters today, there is a possibility that both the multiple valuation will increase and that earnings per share will start to grow rapidly, which will have a double effect on the share price. Conclusion Aino Health AB has transformed into a company with strong tailwinds. The fundamental picture shows accelerating growth, rapidly improving profitability and a scalable SaaS model that is now starting to deliver positive cash flow. Strategically, Aino is positioning itself at the right time by combining AI and health data in a service that addresses both private and public customers' urgent need to reduce sick leave. Several triggers are in the cards – from new customer contracts to the approaching profit turnaround – that could lift the company further in the coming years. Aino Health AB, as of June 2025, is well positioned to provide high returns to the investor who steps on board today.
- ·23.12.2024Why is it up for auction?·23.12.2024In the event of unusually large trade/price fluctuation, an auction will be held to calm down the trade.
- ·12.10.2023How should you think about the obligation to bid? Do you see any alternatives?
- 9.6.2022 · Muokattu9.6.2022 · MuokattuJag har haft Aino länge och har därmed sett innehavet minska i värde med ca 80%. Men det finns säkert folk som förlorade ännu mer då aktien gick ner med 96,39% sedan introduktionen. Samtidigt sitter ledningen kvar och vad jag kan se kör de på i gamla spår. Därför vill jag ställa en ärlig fråga till alla Aino-ägare: varför behåller ni aktien? Vad är det ni ser som kan rimligtvis komma att ändra riktningen på bolaget? Kassan är tom (igen) men företaget har säkrat ett konvertibellån. Detta lån kommer att stämplas om till aktier för att det är ju ändå högst osannolikt att Aino, som har misslyckats med att visa lönsamhet under sex år i rad, ska börja göra det i år. Nivån som konverteringen kommer att göras på är inte satt i dagsläget men det lär knappast bli 60-70 öre, utan snarare 10-20 öre. Så, varför behåller ni aktien?10.6.2022 · Muokattu10.6.2022 · MuokattuÄr i samma situation med dig - innehavet har redan minskat i värde med ca 80%. Tror inte att det kommer hända något som kan ändra riktningen men vill behålla aktien för två orsaker: 1. Om det skulle hända något super positivt 2. Påminnelse för mig själv att använda stop loss Min andel är också så pass liten att det gör ingen skillnad om jag behåller eller säljer den.
- 31.1.2022 · Muokattu31.1.2022 · MuokattuFörstår inte riktigt hur intresset för Aino kan vara så lågt, tycker de prickar många rätt och har ett riktigt intressant case på gång.Poistettu31.1.2022 · MuokattuPoistettu31.1.2022 · Muokattuunder = kunder
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
295 100
Myynti
Määrä
12 437
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 92 000 | - | - | ||
| 8 000 | - | - |
Ylin
0,171VWAP
Alin
0,171VaihtoMäärä
0 100 000
VWAP
Ylin
0,171Alin
0,171VaihtoMäärä
0 100 000
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 100 000 | 100 000 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 100 000 | 100 000 | 0 | 0 |